Summary
- Immunotherapy has revolutionized the treatment of cancer, improving survival rates in melanoma, lung, bladder, and breast cancer.
- A study presented at the ESMO Congress shows that almost half of patients with metastatic melanoma treated with immunotherapy are cancer-free 10 years later.
- Long-term impact of immunotherapy was found to be positive with no worrying signs of toxicity.
- More research is needed to identify which patients will benefit most from immunotherapy and to optimize its potential through different drug combinations.